Trademark/Service Mark Application, Principal Register
Under the Paperwork Reduction Act of 1995 no persons are required to respond to a collection of information unless it displays a valid OMB control number.
PTO Form 1478 (Rev 09/2006)
OMB No. 0651-0009 (Exp 02/28/2021)
Trademark/Service Mark Application, Principal Register
Research and development services in the fields of drug discovery, drug discovery products, pharmaceuticals, medicinal diagnostics, biological
products, medical apparatus, devices and instruments; conducting clinical trials; scientific consulting; supply of information in the area of laboratory technology; medical laboratory services;
provision of scientific information via Internet portals.
Providing health and medical information about medical disorders; counselling and charitable services, namely providing information and
assistance with respect to health and health awareness; provision of medical information via Internet portals; all the aforesaid consultations and services also provided by means of a database.
Christopher M. Hanes, Terence A. Dixon and Michele A. Farber
CORRESPONDENCE INFORMATION
NAME
Merilee J. Arevalo
FIRM NAME
GSK
INTERNAL ADDRESS
LBP, 5.5A
STREET
5 Moore Drive
CITY
Research Triangle Park
STATE
North Carolina
COUNTRY
United States
ZIP/POSTAL CODE
27709
PHONE
919-315-8204
FAX
919-315-3023
*EMAIL ADDRESS
trademarks@gsk.com
*AUTHORIZED TO COMMUNICATE VIA EMAIL
Yes
FEE INFORMATION
APPLICATION FILING OPTION
TEAS RF
NUMBER OF CLASSES
3
APPLICATION FOR REGISTRATION PER CLASS
275
*TOTAL FEE DUE
825
*TOTAL FEE PAID
825
SIGNATURE INFORMATION
SIGNATURE
/Merilee J. Arevalo/
SIGNATORY'S NAME
Merilee J. Arevalo
SIGNATORY'S POSITION
Attorney of record, New Jersey bar member
SIGNATORY'S PHONE NUMBER
919-315-8204
DATE SIGNED
11/05/2019
Under the Paperwork Reduction Act of 1995 no persons are required to respond to a collection of information unless it displays a valid OMB control number.
PTO Form 1478 (Rev 09/2006)
OMB No. 0651-0009 (Exp 02/28/2021)
Trademark/Service Mark Application, Principal Register
Serial Number:88680772
Filing Date:11/05/2019
To the Commissioner for Trademarks:
MARK: VIIV (Standard Characters, see mark)
The literal element of the mark consists of VIIV. The mark consists of standard characters, without claim to any particular font style, size, or color.
The applicant, ViiV Healthcare UK Limited, a private company limited by shares (prc) legally organized under the laws of England, having an address of
980 Great West Road
Brentford, Middlesex TW89GS
England
requests registration of the trademark/service mark identified above in the United States Patent and Trademark Office on the Principal Register established by the Act of July 5, 1946 (15 U.S.C.
Section 1051 et seq.), as amended, for the following:
International Class 041: Educational services, namely conducting seminars regarding health and health awareness and dissemination of materials in connection therewith.
Based on Foreign Registration: The applicant has a bona fide intention, and is entitled, to use the mark in commerce on or in connection with the identified goods/services, and submits a copy of
United Kingdom registration number 2518089, and/or proof of renewal, registered 06/10/2009 with a renewal date of 01/24/2019 and an expiration date of 06/10/2029, and translation thereof, if
appropriate.
The foreign registration that is the basis of the U.S. application under §44(e) of the Trademark Act includes a claim of standard characters or the country of origin's standard character
equivalent.
International Class 042: Research and development services in the fields of drug discovery, drug discovery products, pharmaceuticals, medicinal diagnostics, biological products, medical
apparatus, devices and instruments; conducting clinical trials; scientific consulting; supply of information in the area of laboratory technology; medical laboratory services; provision of scientific
information via Internet portals.
Based on Foreign Registration: The applicant has a bona fide intention, and is entitled, to use the mark in commerce on or in connection with the identified goods/services, and submits a copy of
United Kingdom registration number 2518089, and/or proof of renewal, registered 06/10/2009 with a renewal date of 01/24/2019 and an expiration date of 06/10/2029, and translation thereof, if
appropriate.
The foreign registration that is the basis of the U.S. application under §44(e) of the Trademark Act includes a claim of standard characters or the country of origin's standard character
equivalent.
International Class 044: Providing health and medical information about medical disorders; counselling and charitable services, namely providing information and assistance with respect to
health and health awareness; provision of medical information via Internet portals; all the aforesaid consultations and services also provided by means of a database.
Based on Foreign Registration: The applicant has a bona fide intention, and is entitled, to use the mark in commerce on or in connection with the identified goods/services, and submits a copy of
United Kingdom registration number 2518089, and/or proof of renewal, registered 06/10/2009 with a renewal date of 01/24/2019 and an expiration date of 06/10/2029, and translation thereof, if
appropriate.
The foreign registration that is the basis of the U.S. application under §44(e) of the Trademark Act includes a claim of standard characters or the country of origin's standard character
equivalent.
The applicant hereby appoints Merilee J. Arevalo. Other appointed attorneys are Christopher M. Hanes, Terence A. Dixon and Michele A. Farber. Merilee J. Arevalo of GSK, is a member of the XX
bar, admitted to the bar in XXXX, bar membership no. XXX, and the attorney(s) is located at
LBP, 5.5A
5 Moore Drive
Research Triangle Park, North Carolina 27709
United States
919-315-8204(phone)
919-315-3023(fax)
trademarks@gsk.com (authorized).
The attorney docket/reference number is 82842788.
Merilee J. Arevalo submitted the following statement: The attorney of record is an active member in good standing of the bar of the highest court of a U.S. state, the District of Columbia, or any
U.S. Commonwealth or territory.
The applicant's current Correspondence Information:
Merilee J. Arevalo
GSK
LBP, 5.5A
5 Moore Drive
Research Triangle Park, North Carolina 27709
919-315-8204(phone)
919-315-3023(fax)
trademarks@gsk.com (authorized).
Email Authorization: I authorize the USPTO to send email correspondence concerning the application to the applicant, the applicant's attorney, or the applicant's domestic representative at the
email address provided in this application. I understand that a valid email address must be maintained and that the applicant or the applicant's attorney must file the relevant subsequent
application-related submissions via the Trademark Electronic Application System (TEAS). Failure to do so will result in the loss of TEAS Reduced Fee status and a requirement to submit an additional
processing fee of $125 per international class of goods/services.
A fee payment in the amount of $825 has been submitted with the application, representing payment for 3 class(es).
Declaration
Declaration Signature
Signature: /Merilee J. Arevalo/ Date: 11/05/2019
Signatory's Name: Merilee J. Arevalo
Signatory's Position: Attorney of record, New Jersey bar member
Payment Sale Number: 88680772
Payment Accounting Date: 11/05/2019
Serial Number: 88680772
Internet Transmission Date: Tue Nov 05 15:18:18 EST 2019
TEAS Stamp: USPTO/BAS-XXX.XX.XX.X-201911051518182870
96-88680772-7005dd7a715dd4b7790ab7eb722d
1fb6564748ec0d01778a0999791b2e498c5a88-D
A-18182175-20191105092552270443